Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health FDA Peptide Reclassification 2026: What Researchers Want Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA Peptide Update: Category 2 Removals Explained The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them